SecBot SecBot

Strengthening Pharmacy Access for Seniors Act

S. 2405 Sen. John Thune (R-SD) In committee
  1. Introduced Jul 20
  2. Committee Jul 20
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jul 20, 2023Next: Senate vote
1196d ago Jul 20, 2023: Read twice and referred to the Committee on Finance. (text: CR S3461-3462)
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Member trades
3trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Financials 1
Search all 1 companies, their asks and price moves Subscribe

Summary

Strengthening Pharmacy Access for Seniors Act

Full summary2 paragraphs

This bill prohibits prescription drug plan (PDP) sponsors and pharmacy benefit managers from restricting access to any covered drug under the Medicare prescription drug benefit to a subset of their network pharmacies except for limited access drugs. Limited access drugs are those for which the Food and Drug Administration has restricted distribution to certain facilities or physicians or for which dispensing requires extraordinary special handling, coordination, or education that a network pharmacy cannot meet.

PDP sponsors must annually report to the Centers for Medicare & Medicaid Services (1) a list of drugs that the PDP sponsor designated as limited access drugs, (2) the reasons for the designations, (3) information about relevant requirements for pharmacies with respect to these drugs, and (4) the types of pharmacies dispensing these drugs.

Library of Congress summary, Jul 20, 2023

Summary versions
  • Introduced in SenateJul 20, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.